Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Novel Photoprotective Cosmetics: From Fundamental Science to Product

Project description

New sunscreen formulation for better protection

High quality sunscreen is important for photoprotection with increasing numbers of people being diagnosed with skin cancer each year than all other cancers combined. The EU-funded SUNNRL project is developing a sunscreen product to deliver effective, safe and inexpensive broad-spectrum photoprotection. It will bring to market an alternative ultraviolet-A (UVA) filter. Current market leader is the UVA filter avobenzone, which quickly degrades upon absorption of UV radiation, thus posing a significant risk to human health. The few currently available alternatives to avobenzone are too expensive. The development of this sun care formulation at Spain’s company Lipotec will further the European scientific and technical leadership. It will also address the Horizon 2020 societal challenges regarding health and wellbeing.

Objective

Drawing on the expertise from the applicants’ publications, wider academic research and recent contact with Lipotec, a global leader in Skin and Sun Care, this MSCA-IF-EF-SE application proposes to develop a novel sunscreen product which will deliver effective, safe and inexpensive broad-spectrum photoprotection. This project is aimed particularly at providing the global sunscreen industry with an alternative ultraviolet-A (UVA) filter: the UVA filter currently leading the market, avobenzone, quickly degrades upon absorption of UV radiation thus posing a significant risk to human health. The few currently available alternatives to avobenzone are too costly, resulting in unaffordable photoprotective products to consumers, which may have implications in skin cancer incidence. To develop this innovative, high-demand UVA-focused sunscreen product, the applicant will combine the sunscreen molecules she studied during her doctoral degree with the state-of-the-art cosmetic delivery system technology developed by Lipotec. The development of this product at Lipotec (Barcelona) will further the European scientific and technical leadership, as well as boosting the European Sun Care market and addressing the Horizon 2020 societal challenges regarding health and wellbeing.

Coordinator

LIPOTEC SA
Net EU contribution
€ 172 932,48
Address
CALLE ISAAC PERAL 17
08850 Gava Barcelona
Spain

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 172 932,48